Close Menu

NEW YORK (GenomeWeb) – Danaher reported before the opening of the market on Thursday that its first quarter sales rose 7 percent year over year.

For the three months ended March 31, the firm reported revenues of $4.21 billion, up from $3.92 billion in Q1 2016, and beating the average Wall Street estimate for sales of $4.17 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.